Refractory Bartonella quintana bacillary angiomatosis following chemotherapy for chronic lymphocytic leukaemia.
Bacillary angiomatosis is a well-recognized infection with cutaneous and systemic manifestations caused by Bartonella henselae or Bartonella quintana and occurs in immunocompromised patients. We report a case of B. quintana bacillary angiomatosis following fludarabine-based chemotherapy for chronic lymphocytic leukaemia that was refractory to standard treatment and was complicated by lymphadenopathy and osteomyelitis.
Holmes
Natasha E
NE
Department of Infectious Diseases, Southern Health, 246 Clayton Road, Clayton, VIC 3168, Australia.
Opat
Stephen
S
Department of Haematology, Southern Health, 246 Clayton Road, Clayton, VIC 3168, Australia.
Kelman
Anthony
A
Department of Anatomical Pathology, Southern Health, 246 Clayton Road, Clayton, VIC 3168, Australia.
Korman
Tony M
TM
Department of Medicine, Monash University, Clayton, VIC 3168, Australia.|Department of Infectious Diseases, Southern Health, 246 Clayton Road, Clayton, VIC 3168, Australia.
D000368:Aged; D016917:Angiomatosis, Bacillary / Q000175:diagnosis* / Q000188:drug therapy* / Q000382:microbiology / Q000473:pathology; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001431:Bacteriological Techniques / Q000379:methods; D018413:Bartonella quintana / Q000302:isolation & purification*; D004358:Drug Therapy / Q000379:methods*; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000150:complications* / Q000188:drug therapy*; D008206:Lymphatic Diseases / Q000473:pathology; D008853:Microscopy / Q000379:methods; D010019:Osteomyelitis / Q000382:microbiology; D017211:Treatment Failure; D014740:Vidarabine / Q000031:analogs & derivatives / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D014740:Vidarabine; C024352:fludarabine